Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • unique379
    Member
    • Aug 2012
    • 27

    #1

    differential expression of Novel miRNA and its validation

    Hello all,
    Could someone suggest me that how to discriminate control vs treatment of predicted novel miRNA by mirdeep2 ??? in order to validate the potent Novel DE miRNA ???

    I mean, i have discriminated before validation by sequence identity control vs treatment. Means picked the only mature seq of treatment(from all libraries) that were not identical present into control (was only in one library as mature but were consider not expressed) and done RT-qPCR. However, validation result was surprising that particular mature seq was present in all libraries (control and treatment both) !!!!

    Then i looked once again in all libraries of results.csv. And i found that seq was present either in star form or in precursor but not in mature. Tjherefore for that pre-mir, predicted mature was different.

    How this happened ???

    Some please help me that how i can be sure novel DE miRNA that predicted by miRDeep2 before to validation by RT-qPCR ???

    thanks
    Last edited by unique379; 05-23-2014, 12:00 AM.
  • xunong
    Junior Member
    • Sep 2014
    • 9

    #2
    I have the same problem!
    Can anyone give a proper suggestion?

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 10-22-2026, 11:13 AM
    0 responses
    56 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-22-2026, 10:48 AM
    0 responses
    41 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    46 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    46 views
    0 reactions
    Last Post SEQadmin2  
    Working...